首页> 外文期刊>Expert opinion on investigational drugs >17-AAG: mechanisms of antitumour activity
【24h】

17-AAG: mechanisms of antitumour activity

机译:17-AAG:抗肿瘤活性的机制

获取原文
获取原文并翻译 | 示例
       

摘要

Heat-shock protein 90 (Hsp90) is a molecular chaperone involved in three-dimensional folding,intracellular translocation and degradation of multiple key regulatory proteins.Accumulated evidence has indicated an important role of Hsp90 in several signal transduction pathways that are deregulated in carcinogenesis.17-Allylamino-17-demethoxygeldanamycin (17-AAG),a selective inhibitor of Hsp90,is currently under clinical investigation in advanced malignancies in which Hsp90 client proteins are implicated.This article discusses the mechanistic evidence underlying 17-AAG's cytostatic,pro-apoptotic,antiangiogenic and anti-invasive properties that provide the basis for its antitumour activity and underscores its unique therapeutic potential as a multi-targeted agent,as opposed to most of the current-generation molecular therapeutics.
机译:热休克蛋白90(Hsp90)是一种分子伴侣,参与三维折叠,细胞内易位和多种关键调控蛋白的降解。积累的证据表明,Hsp90在致癌过程中被解除调控的几种信号转导途径中具有重要作用.17 -Hsp90的选择性抑制剂-Allylamino-17-demethoxymethoxyddanamycin(17-AAG)目前正在与Hsp90客户蛋白相关的晚期恶性肿瘤中进行临床研究。本文讨论了17-AAG的细胞生长抑制性,促凋亡性,抗血管生成和抗侵袭特性为其抗肿瘤活性提供了基础,并强调了其作为多靶点药物的独特治疗潜力,这与大多数当前的分子疗法相反。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号